Atlas Trials

A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy

Clinical trial NCT04513366 · COMPLETED

Trial details

NCT number
NCT04513366
Sponsor
Swedish Orphan Biovitrum
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Gout
Start date
2020-08-18
Primary completion
2022-07-21
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.